학술논문
PD-0001 - Cetuximab Every 2 Weeks with First-Line Chemotherapy in APEC Study Patients with Metastatic Colorectal Cancer Grouped According to EGFR Expression
Document Type
Abstract
Author
Source
In Annals of Oncology June 2014 25 Supplement 2:ii5-ii5
Subject
Language
ISSN
0923-7534